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566 The Journal of Thoracic and Cardbjective: In patients undergoing cardiac surgery, intraoperative myocardial acido-
is, which quantifies regional myocardial ischemia, has been shown to increase the
isk of adverse postoperative outcomes. In this study, we sought to determine the
ourse of intraoperative myocardial acidosis and its impact on postoperative sur-
ival in patients with diabetes mellitus undergoing cardiac surgery.
ethods: Intraoperative myocardial tissue pH37C was continuously measured in the
nterior and posterior left ventricular walls in 264 patients undergoing cardiac
urgery; 74 (28.0%) of the patients had diabetes (insulin-dependent diabetes: 54%;
on–insulin dependent diabetes: 46%). The shortest time required to reach intraop-
rative myocardial tissue pH  6.34 during aortic occlusion and  6.73 during
eperfusion were compared in 3 patient groups: insulin-dependent, non–insulin
ependent, and nondiabetic. These pH thresholds have been demonstrated to be
ssociated with adverse postoperative long-term survival.
esults: The median times to reach intraoperative myocardial tissue pH37C  6.34
uring aortic occlusion were 14, 23, and 36 minutes in the insulin-dependent,
on–insulin dependent, and non-diabetic groups, respectively (P  .003). The time
aken to reach intraoperative myocardial tissue pH37C  6.73 during reperfusion
as similar between the 3 groups. After adjusting for relevant pre- and intraoper-
tive parameters, the risk of developing intraoperative myocardial tissue pH  6.34
uring aortic occlusion was 73% higher in patients with insulin-dependent diabetes
ellitus (P  .022) but the same in with patients with non–insulin dependent
iabetes mellitus (P  .98) when compared with patients without diabetes. Patients
ith insulin-dependent diabetes mellitus also had nearly threefold decrease in
ong-term survival compared with that of patients without diabetes (P  .0007).
onclusions: Patients with insulin-dependent diabetes mellitus undergoing cardiac
urgery are at a greater risk of developing intraoperative myocardial acidosis/
schemia and of decreased survival postoperatively compared with patients without
iabetes.
ore than 18 million Americans or about 6% of the total population of the
United States have diabetes mellitus (DM).1 Its national prevalenc
among patients undergoing coronary artery bypass graft (CABG) surgery
s as high as 28%.2 It is also a well-established risk factor for adverse outc
ollowing cardiac surgery.3-5 Any strategy that could improve outcomes in 
roup of patients would be a welcome addition to the surgical armamentari
Earlier studies from our institution demonstrated that myocardial tissue pH could
e used as a reliable on-line measure of myocardial tissue ischemia during cardiac
urgery,6,7 resulting in the development of a clinically usable probe.8
iovascular Surgery ● June 2007
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CS
PWe recently demonstrated that intraoperative myocardial
cidosis is associated with decreased long-term survival
fter cardiac surgery. In a cohort of 496 patients undergoing
ardiac surgery who were followed for an average of 10.2
ears, we determined that mean myocardial tissue pH, cor-
ected to 37°C (pH37C)  6.34 during aortic occlusion and
H37C  6.73 at the end of reperfusion, were independent
redictors of decreased long-term survival.9 In other stud-
es, regional myocardial acidosis was shown to correlate
ith an increased risk of other adverse outcomes after
ardiac surgery, including the need for intraoperative ino-
ropic support,10 30-day mortality and morbidity,11 and
nplanned hospital readmissions within 30 days and 6
onths.12
During the initial years of intraoperative metabolic mon-
toring, we passively monitored the myocardial tissue pH
nd observed how the myocardial pH varied as a result of
ifferent surgical and reperfusion practices. Subsequently,
e developed specific methods and maneuvers aimed at
educing regional myocardial acidosis/ischemia intraopera-
ively. Collectively, these strategies formed the practice of
pH-guided myocardial management.”13
Abbreviations and Acronyms
ATP  adenosine triphosphate
CABG  coronary artery bypass graft
CI  confidence interval
DM  diabetes mellitus
IDDM  insulin-dependent diabetes mellitus
NIDDM non–insulin dependent diabetes mellitus
pH37C myocardial tissue pH, corrected to 37°C
RR  relative risk
VA  Veterans Affairs
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The Journal of ThoracicThe present study was undertaken during the period of
yocardial pH monitoring in which intraoperative efforts to
lter myocardial acidosis were not aggressively pursued. It
imed to quantify the risk and assess the impact of the
evelopment of intraoperative myocardial acidosis/ischemia
uring on-pump cardiac surgery in patients with diabetes
ellitus.
aterials and Methods
atient Population
etween 1987 and 1997, 264 patients underwent intraoperative
n-line monitoring of myocardial tissue pH at the Veterans Affairs
VA) Medical Center, West Roxbury, Massachusetts; complete pH
ata for these patients, as well as data relating to DM status,
ncluding whether insulin dependent or not, were available. These
atients were a subgroup of the cohort of 496 patients in whom
ifferences in long-term mortality were studied.9 The study wa
pproved by the Institutional Review Board at our institution, and
ll patients provided informed consent.
H37C Measurement
yocardial tissue pH37C was measured using the Khuri Tissue pH
onitoring System (Vascular Technology, Inc, Lowell, Mass) in
dult patients undergoing cardiopulmonary bypass, as previously
escribed.8,14 Two right-angled glass microelectrodes were -
erted perpendicularly, 1 into the anterior and 1 into the posterior
eft ventricular wall, midway between the apex and the base. They
ere inserted immediately after beginning bypass, but before
pplying aortic occlusion, and were removed immediately after the
atient was weaned from bypass. The pH monitoring system
ontinuously measured myocardial tissue pH and temperature. For
ach time point for each patient, the lower of the anterior and
osterior pH37C values was used to define the magnitude of re-
ional myocardial acidosis encountered in that patient (Figure
Regional myocardial acidosis was also defined in terms of
pecific myocardial pH thresholds (6.34 during the period of aortic
lamping and 6.73 during reperfusion). These thresholds have
Off CPB
125
Figure 1. Intraoperative myocardial
tissue pH37C tracing of a 56-year old
man with DM undergoing CABG surgery
with 3 grafts. Cardioplegic solution was
given in boluses through the aortic root
at the beginning of aortic occlusion and
through the proximal ends of the newly
constructed grafts (indicated by ar-
rows). The mean pH37C during aortic
occlusion indicated severe acidosis in
both walls despite a total administra-
tion of 3500 mL of 4:1 blood cardioplegic
solution. DM, diabetes mellitus; CABG,
coronary artery bypass graft.and Cardiovascular Surgery ● Volume 133, Number 6 1567
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1
CSPeen previously identified to be significant independent predictors
f decreased long-term patient survival after cardiac surgery.9
erfusion and Myocardial Management Techniques
ither mild hypothermia (25°C) and topical cooling with ice slush
sing conventional bypass circuits (1987–1995) or systemic nor-
othermia (34°C-37°C) with heparin-bonded bypass circuits
1996–1997; Duraflo, Baxter Corp, Irvine, Calif) was used. Cold
rystalloid cardioplegic solution or 4:1 blood cardioplegic solution
as used for CABG procedures. When an operation included a
oncomitant valve replacement, 4:1 blood cardioplegic solution
as used exclusively since 1991. In isolated CABG procedures,
he distal anastomoses were performed first, through a single
eriod of aortic clamping. The proximal anastomoses were per-
ormed by applying a side-biting clamp to the ascending aorta
uring reperfusion. In isolated CABG procedures, antegrade car-
ioplegic solution was delivered through the aortic root and
hrough the proximal ends of constructed grafts; it was interrupted
nly during the construction of the distal anastomoses. In proce-
ures where CABG surgery was combined with aortic valve re-
lacement, the saphenous vein grafts were constructed first. Car-
ioplegic solution was initially given antegrade through the aortic
oot and subsequently through the orifice of the left main coronary
rtery and through the constructed grafts. During the valve replace-
ent, cardioplegia was interrupted over 20-minute periods only
hen it interfered with the visualization of the operative field.
ata Collection
pecifically trained nurses and research assistants prospectively
ollected preoperative and intraoperative data on all patients, in-
luding diabetes status and whether insulin dependent or not.
ata on Diabetes
patient was defined as being nondiabetic if the patient was
ormoglyemic or had hyperglycemia that was controlled by exer-
ise and diet modifications alone. A patient was defined as having
on–insulin dependent diabetes mellitus (NIDDM) if the patient
equired therapy with an oral hypoglycemic agent during the 2
eeks prior to surgery, and as having insulin-dependent diabetes
ellitus (IDDM) if the patient required daily insulin therapy
uring the 2 weeks prior to surgery.
ata on Long-term Survival
he patients were tracked through the electronic patient records of
he VA Boston Healthcare System and 9 additional referring VA
edical centers in New England, research records of clinical
tudies in which many of the patients had been enrolled, and the
A Beneficiary Identification and Record Locator System, which
as been shown to be 95% accurate in depicting the vital status of
S veterans.9,15
ata and Statistical Analysis
nly patients with complete pH data, as well as data relating to
M status, were included in the analysis, which resulted in a data
et of 264 patients. Missing values for other variables were not
mputed. Age, body surface area, preoperative ejection fraction,
reoperative serum creatinine, duration of aortic clamping and
ypass, and total volume of cardioplegic solution used were treated b
568 The Journal of Thoracic and Cardiovascular Surgery ● Juns continuous variables. Only the operating surgeon (n  3) was
reated as a categorical variable, for which the surgeon with the
owest adverse outcomes rates was chosen as the reference cate-
ory. All other variables, including year of study (1987–1990,
991–1997) and type of surgery (CABG, valve  CABG), were
reated as binary variables. Preoperative and intraoperative char-
cteristics of the 3 study groups were compared using chi-square
ests (or Fisher exact tests where necessary) for binary and cate-
orical variables and analysis of variance for continuous variables.
aplan–Meier curves compared the shortest times required by the
patient groups to develop regional myocardial acidosis during
ortic occlusion (6.34) and for the reversal of this acidosis during
eperfusion (6.73), as well as the long-term survival of the 3
atient groups.16 The Cox proportional hazards regression mod
as used to evaluate the relationship between risk factors and the
evelopment of acidosis, as well between diabetes and long-term
urvival.17 Initially, relative risks (RRs) and their confidence -
ervals (CIs) were estimated in a univariate model. Relevant pre-
nd intraoperative variables were then entered into a multivariate
nalysis. Two-way interactions of important risk factors were
xamined for statistical significance.
All statistical analyses were performed using SAS version 9.1
SAS Institute, Cary, NC). All P values were two-tailed. All CIs
ere calculated at the 95% level.
esults
etween January 1987 and September 1997, 264 patients
nderwent cardiac surgery with intraoperative on-line mon-
toring of myocardial tissue pH; complete pH and diabetes
nformation were available for these patients. Of these, 74
28%) had DM; among them were 40 (54%) with NIDDM
nd 34 (46%) with IDDM. The distribution of preopera-
ive and intraoperative characteristics between the 3 study
roups—IDDM, NIDDM, and nondiabetic—are shown in
he Table 1. Patients with DM tended to have a larger
urface area, a higher preoperative serum creatinine, and a
igher prevalence of peripheral vascular disease. After ad-
usting for multiple comparisons, patients with IDDM had
ignificantly higher serum creatinine values compared with
oth patients without DM and patients with NIDDM (P 
0017), and both patients with NIDDM and patients with
DDM had significantly higher incidence of femoral-popli-
eal disease as compared with patients without DM (P 
017). At our institution, patients with DM were more likely
o undergo CABG surgery than valve surgery. Patients with
M, particularly those with IDDM, also tended to have a
ignificantly lower pH37C prior to aortic occlusion. There
as also a statistical trend observed toward low mean pH37C
uring aortic occlusion in patients with DM compared with
atients without DM. After adjusting for multiple compar-
sons, patients with IDDM had a significantly lower pH37C
ompared with patients without DM (6.45 vs 6.57; P 
017).
Kaplan–Meier curves comparing the shortest time taken
y the 3 patient groups to develop regional myocardial
e 2007
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Pcidosis (pH37C  6.34) during aortic occlusion are shown
n Figure 2. Patients with DM developed intraopera
cidosis earlier than did patients without DM after aortic
cclusion. The median times were 14 minutes, 23 minutes,
nd 36 minutes for patients with IDDM, patients with
IDDM, patients without DM (log–rank test P  .003).
here was no difference in the shortest time taken to reverse
egional myocardial acidosis during reperfusion between the 3
roups: the median times were 11 minutes, 6 minutes, and 7
inutes for patients with IDDM, patients with NIDDM, and
atients without DM, respectively (log–rank test P  .70).
Univariate Cox regression analysis, with time to devel-
pment of regional acidosis during aortic occlusion as the
ependent variable, revealed that patients with NIDDM had
31% greater risk of developing intraoperative myocardial
cidosis when compared with patients without DM (RR 
ABLE 1. Baseline characteristics of study population
ariable Nondiabetics
reoperative or demographic variables
Age (y) 64.9 
Female 4 (2.1
Prior myocardial infarction 70 (41.
NYHA class III/IV 107 (58.
ASA class IV/V 51 (27.
Current smoker 57 (30.
Emergency surgery 7 (3.8
Body surface area (kg/m2) 1.9 
Preoperative ejection fraction (%) 50.2
Chronic obstructive pulmonary disease 57 (30.
Serum creatinine before surgery (mg%) 1.2
Presence of femoral-popliteal disease 32 (17.
Surgeon
No. 1 121 (63.
No. 2 63 (33.
No. 3 5 (2.6
ype of operation
CABG 94 (49.
Valve CABG 96 (50.
ntraoperative variables
Duration of bypass (min) 165.3
Duration of aortic occlusion (min) 89.8
Total amount of cardioplegic solution, per
hour of aortic occlusion (mL)
3292.7
Crystalloid cardioplegic solution 21 (11.
Internal thoracic artery use 50 (26.
pH37C prior to aortic occlusion 6.64
Mean pH37C during aortic occlusion 6.57
Mean pH37C  6.34 during aortic occlusion 33 (17.
pH37C at end of reperfusion 6.98
Chi-square/Fisher exact test for binary/categorical variables and analysis
ellitus; IDDM, insulin-dependent diabetes mellitus; NYHA, New York He
rtery bypass graft surgery; (ref), reference category; pH37C,  myocardi
eviation, unless mentioned otherwise..31, 95% CI  0.87-1.96; P  .2). In contrast, patients i
The Journal of Thoracicith IDDM had a significantly elevated 95% greater risk
RR  1.95, 95% CI  1.29-2.96; P  .002) when com-
ared with patients without DM. The final multivariate
odel, which was adjusted for relevant covariates, includ-
ng age, gender, New York Heart Association class, Amer-
can Society of Anesthesiologists class, smoking status,
ody surface area, serum creatinine before surgery, pres-
nce of peripheral vascular disease, type of surgery, year of
urgery, surgeon, and type of cardioplegic solution used,
evealed that patients with IDDM continued to have a
ignificantly higher risk of developing intraoperative myo-
ardial ischemia when compared with patients without DM
RR  1.73, 95% CI  1.08-2.75; P  .022). The risk for
atients with NIDDM was nonsignificant (RR  1.01, 95%
I  0.60-1.68; P  .98).
Data on long-term survival were available for all patients
190) NIDDM (n  40) IDDM (n  34) P*
65.8 8.4 63.8 9.9 .67
1 (2.5%) 1 (2.9%) .76
22 (57.9%) 20 (58.8%) .055
18 (45.0%) 19 (55.9%) .28
12 (30.0%) 12 (35.3%) .64
12 (30.0%) 9 (26.5%) .90
2 (5.0%) 2 (5.9%) .54
2.0 0.2 2.0 0.2 .045
53.7 16.0 46.5 18.3 .32
14 (35.0%) 12 (35.3%) .75
1.1 0.3 1.4  0.9 .0031
14 (35.0%) 17 (50.0%) .0001
25 (62.5%) 20 (58.8%) .87
15 (37.5%) 12 (35.3%) .86
0 2 (5.9%) .74
23 (57.5%) 26 (76.5%) (ref)
17 (42.5%) 8 (23.5%) .013
157.5 46.4 143.6 49.3 .16
84.8 34.7 75.5 38.5 .16
0 3089.5 2160.4 2632.8 1915.9 .40
3 (7.5%) 2 (5.9%) .29
12 (30.0%) 12 (35.3%) .56
6.63 0.33 6.49 0.26 .033
6.54 0.31 6.45 0.31 .12
9 (22.5%) 11 (32.4%) .13
7.01 0.31 6.91 0.34 .34
riance for continuous variables. NIDDM, Non-insulin dependent diabetes
sociation; ASA, American Society of Anesthesiologists; CABG, coronary
ue pH adjusted to 37°C. Values in the table represent mean  standard(n 
9.7
%)
4%)
8%)
4%)
3%)
%)
0.2
16.5
3%)
0.3
2%)
7%)
2%)
%)
5%)
5%)
63.7
41.6
2640.
1%)
6%)
0.28
0.31
55%)
0.33
of va
art As
al tissn our cohort, with a mean follow-up of 10.2 years, as
and Cardiovascular Surgery ● Volume 133, Number 6 1569
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CSPentioned earlier. Accordingly, we compared the long-te
urvival of the 3 groups of patients and found tha
edian survival in patients with IDDM was 4.59 year
ompared with a median survival of 11.07 years in pa
ithout DM. Although the 50th percentile for mortalit
atients with NIDDM was not defined, the survival cu
or patients with NIDDM and patients without DM 
eared to be similar. The log–rank test comparing the
ival curves had a P value of .0014 (Figure 3). The adjus
azard ratio of long-term mortality was 0.97 (95% C
.50-1.85; P  .92) in patients with NIDDM and 2.62 (9
I  1.50-4.57; P  .0007) in patients with IDDM wh
ompared with patients without DM, indicating that o
atients with IDDM had an adverse postoperative surv
ompared with patients without DM.
We also compared immediate postoperative outcom
mong the 3 groups. There was no difference betw
atients without DM, patients with NIDDM, and pati
ith IDDM in the incidence of 30-day mortality (4.7%
.5% vs 0; P  .19) or perioperative myocardial ischem
5.9% vs 7.5% vs 8.8%; P  .80).
iscussion
ased on our observation that the median time to develop
f intraoperative myocardial acidosis after crossclamp w
ignificantly lower in patients with IDDM than in pat
ithout DM, the principal finding of our study is that pa
ith IDDM are more vulnerable to the development of 
perative myocardial acidosis during cardiac surgery than 
ients without DM. They had a statistically significant 
igher risk of developing regional myocardial acidosis c
0.00
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P
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igure 2. Kaplan–Meier curves comparing the median times
aken to develop regional myocardial acidosis during aortic
cclusion (pH < 6.34) in the 3 patient groups: IDDM (insulin-
ependent diabetes mellitus), NIDDM (non–insulin dependent
iabetes mellitus), and nondiabetic. The median times were
4, 23, and 36 minutes, respectively (log–rank test P  .003).ared with patients without DM, after adjusting for relevanti
570 The Journal of Thoracic and Cardiovascular Surgery ● June
s
s
-
s
t
ts
-
linical variables. They also showed a nearly threefold incr
n their long-term mortality compared with patients wit
M. There was no significant difference in the risk of 
ping intraoperative myocardial acidosis or long-term surv
n patients with NIDDM when compared with patients wit
M. A greater emphasis on myocardial protection in pat
ith IDDM is thus necessary. To the best of our know
his is the first clinical study demonstrating an increased
eptibility to developing intraoperative myocardial acidosis
atients with IDDM.
Our findings that patients with DM have a higher 
lence of obesity, peripheral vascular disease, and r
nsufficiency are consistent with current knowledge ab
iabetes.3,4,18 They may also have more advanced, diff
oronary disease, making myocardial management duri
ABG surgery more difficult and less successful.18 Numer-
us methods to improve myocardial protection in pati
ith DM have been proposed; including a recent stud
urnary et al,4 who found that a continuous insulin infus
uring the perioperative period to aggressively control 
erglycemia in patients with DM undergoing CABG 
ery (Portland protocol) conferred a survival benefit.
The relationship between regional myocardial acido
nd regional myocardial ischemia has been well establis
yocardial tissue pH, measured with the technology 
loyed in this study, has been shown to be reflectiv
egional myocardial tissue pCO2 measured with mass spec-
rometry.7 Under ischemic conditions, the respective me-
urements of regional myocardial tissue pH and pCO2 have
een shown to correlate with each other7 and with adjacen
Survival Time (Years)
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S
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igure 3. Kaplan–Meier curves comparing long-term survival in
he 3 patient groups: IDDM (insulin-dependent diabetes mellitus),
IDDM (non–insulin dependent diabetes mellitus), and nondia-
etic. Patients with IDDM had a median survival of 4.59 years,
nd patients without DM had a median survival of 11.07 years.
he 50th percentile for mortality in patients with NIDDM was not
efined (log–rank test P  .0014).ntramural ST-segment changes on the electrocardiogram,19
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Pegional myocardial blood flow,20 qualitative ultrastructural
schemic changes,6,20 and intracellular pH and intracellul
igh-energy phosphates.21 Therefore, myocardial acidosi
n the patient population studied can be considered a surro-
ate for regional myocardial ischemia.
Mechanistically, there could be several reasons that ex-
lain why patients with DM should be more susceptible to
he development of myocardial acidosis and ischemia dur-
ng the period of aortic clamping. To begin with, patients
ith DM develop hyperglycemia and dyslipidemia-induced
ndothelial dysfunction, with resultant advanced macroan-
iopathy and microangiopathy in the vascular system, in-
luding in the coronary circulation.22 Moreover, studies
ave also demonstrated that despite angiographically nor-
al epicardial coronary arteries, the coronary vasodilator
eserve is frequently impaired in patients with DM23; be-
ause of this, the washout of H may be impaired as a result
f poor perfusion, leading to localized acidosis in the myo-
ardium. Similarly, these factors may reduce the capacity of
he diabetic myocardium to sustain prolonged periods of isch-
mia and, in fact, probably engender some amount of isch-
mia in the resting myocardium as well. This correlates very
ell with our observation of a statistically significant lower
yocardial pH37C in patients with DM compared with pa-
ients without DM even prior to aortic occlusion. Once
ubjected to global ischemia following aortic clamping,
heir myocardial reserve is depleted quickly, manifested by
n early drop in pH37C on crossclamp.
At the cellular level, several pathways may be operative,
hich could explain an increased susceptibility of patients
ith IDDM to intraoperative myocardial acidosis. Normal
yocardium utilizes several substrates, including free fatty
cids, glucose, pyruvate, lactate, and ketones for the pro-
uction of adenosine triphosphate (ATP).24 However, insu-
in deficiency impairs both aerobic and anaerobic metabolic
athways of ATP generation, resulting in increased O2
onsumption, buildup of CO2, acetyl coenzyme A, pyru-
ate, and lactic acid,25,26 which in turn results in localiz
espiratory and metabolic acidosis in the tissues. Addition-
lly, ongoing rapid hydrolysis of ATP and lactic acid
uildup lead to a decrease in intracellular pHi and impaired
TP-dependent cellular functions.27,28 Increase in intracel-
ular H concentration results in the accumulation of Na in
he cell due to the activation of Na/H antiporter attempt-
ng to restore internal pH, which in turn results in accumu-
ation of H in the extracellular milieu, contributing further
o the regional acidosis.
The combination of increased acidosis in patients with
M and the adverse impact of intraoperative myocardial
cidosis on long-term survival, which we have recently
eported,9 suggests that patients with IDDM should h
ecreased survival after cardiac surgery compared with that
f patients without DM. Our study confirms this assumption H
The Journal of Thoracicy demonstrating that long-term mortality in patients
ith IDDM is significantly increased by 2.6 times when
ompared with that of patients without DM. Our findings
re in concordance with the findings of other investiga-
ors, who have demonstrated a greater long-term mortal-
ty in patients with DM, both after percutaneous and
urgical revascularization, when compared with patients
ithout DM.3,5,29
Our data are derived from a time period of myocardial
H monitoring when intraoperative efforts to alter myocar-
ial acidosis were not pursued unless pH reached acidotic
evels following the application of aortic crossclamp. Hence,
he mean pH37C during the total period of aortic crossclamp-
ng, which may have been altered by pH-guided myocardial
anagement, would not be as discriminant as the initial
ourse of myocardial pH changes in depicting susceptibility
o acidosis during this period. In the light of the current and
ther outcomes studies,9-12 the development of intraopera-
ive myocardial acidosis during cardiac surgery is aggres-
ively avoided at our institution through the implementation
f pH-guided myocardial management, which is directed at
educing or totally ameliorating intraoperative regional
yocardial acidosis.
The main limitations of the current study are the small
ample size of the study population, the fact that it
manated from a single institution, and that any valida-
ion of these findings would require prospective multi-
enter studies. A multicenter study and other studies all
imed at validating the observations made in the course
f pH-guided myocardial management are currently un-
erway. The small sample size perhaps also hindered our
bility to detect subtle differences in susceptibilities be-
ween patients with NIDDM and patients without DM.
nother limitation of our study is the lack of data on the
evel of glycemic control in our patients, both intraoper-
tively and perioperatively, as reflected by hemoglobin
1c levels. That would have enabled us to study the
elationship between pre- and perioperative glucose lev-
ls and the development of myocardial acidosis during
ortic occlusion and a potential causal relationship be-
ween higher glucose levels and early development of
yocardial acidosis.
In summary, patients with IDDM are more likely to
evelop severe intraoperative regional myocardial ischemic
cidosis during cardiac surgery. They also have signifi-
antly decreased long-term survival compared with patients
ithout DM. A greater emphasis on adequate myocardial
rotection during cardiac surgery in these high-risk patients
s warranted.
We thank Mr Sidney Atwood, Harvard School of Public
ealth, for his help with the statistical analysis.
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